IP Verse

Competitive analysis in Immune Drugs industry

Top companies filing patent oppositions

Company
STRAWMAN LIMITED
Total Oppositions
16
Company
SOCIETE DES PRODUITS NESTLE S.A.
Total Oppositions
8
Company
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Total Oppositions
7
Company
GENERICS [UK] LIMITED
Total Oppositions
7
Company
STADA ARZNEIMITTEL AG
Total Oppositions
6
Company
SANDOZ AG
Total Oppositions
6
Company
HAMM&WITTKOPP PATENTANWALTE PARTMBB
Total Oppositions
6
Company
N.V. NUTRICIA
Total Oppositions
5
Company
JAMES POOLE LIMITED
Total Oppositions
4
Company
ABBOTT LABORATORIES
Total Oppositions
4

Top companies facing patent oppositions

Company
NOVARTIS AG
Total Oppositions
52
Company
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Total Oppositions
20
Company
AMGEN INC.
Total Oppositions
15
Company
AMGEN RESEARCH (MUNICH) GMBH
Total Oppositions
15
Company
N.V. NUTRICIA
Total Oppositions
13
Company
NIPPON SHINYAKU CO., LTD.
Total Oppositions
8
Company
ALKERMES PHARMA IRELAND LIMITED
Total Oppositions
8
Company
F. HOFFMANN-LA ROCHE AG
Total Oppositions
7
Company
CANTARGIA AB
Total Oppositions
6
Company
GLAXOSMITHKLINE BIOLOGICALS S.A.
Total Oppositions
6

Latest patents granted in the Immune Drugs industry

Patent:
EP2736487
Grant Date:
Aug 28, 2024
Title:
New (Trimethoxyphenylamino)Pyrimidinyl Formulations
Applicant:
RIGEL PHARMACEUTICALS, INC.
Patent:
EP3578169
Grant Date:
Jun 26, 2024
Title:
Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol
Applicant:
GLAXO GROUP LIMITED
Patent:
EP3293202
Grant Date:
Feb 7, 2024
Title:
Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses Thereof
Applicant:
CANTARGIA AB
Patent:
EP3028564
Grant Date:
Jan 24, 2024
Title:
Animal Models And Therapeutic Molecules
Applicant:
KYMAB LIMITED
Patent:
EP3444334
Grant Date:
Dec 20, 2023
Title:
Method For Inducing Cd8+ T Cells
Applicant:
KYOTO UNIVERSITY
Patent:
EP3512355
Grant Date:
Nov 8, 2023
Title:
Fermented Nutritional Composition For Cow'S Milk Protein Allergic Subjects
Applicant:
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Patent:
EP3209673
Grant Date:
Jul 26, 2023
Title:
Mixtures Of Hmos
Applicant:
GLYCOM A/S
Patent:
EP3065777
Grant Date:
Jul 12, 2023
Title:
Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host Disease
Applicant:
EVIVE BIOTECHNOLOGY (SHANGHAI) LTD
Patent:
EP3860590
Grant Date:
Jun 7, 2023
Title:
Methods For The Treatment Of Scleroderma
Applicant:
ARENA PHARMACEUTICALS, INC.
Patent:
EP3897608
Grant Date:
May 31, 2023
Title:
Dietary Butyrate For Treating Or Preventing An Allergic Disorder
Applicant:
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.

Top patents facing oppositions in Immune Drugs industry

Patent
EP2780375
Grant Date
Sep 11, 2019
Title
Binding Molecules For Bcma And Cd3
Applicant
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Oppositions
24
Patent
EP2959894
Grant Date
Oct 12, 2022
Title
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant
NOVARTIS AG
Oppositions
23
Patent
EP2780374
Grant Date
Aug 21, 2019
Title
Binding Molecules For Bcma And Cd3
Applicant
AMGEN RESEARCH (MUNICH) GMBH
Oppositions
21
Patent
EP2397142
Grant Date
Jul 27, 2022
Title
Use Of Dpp Iv Inhibitors
Applicant
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Oppositions
10
Patent
EP3253377
Grant Date
May 12, 2021
Title
Monomethylfumarate Prodrug Compositions
Applicant
ALKERMES PHARMA IRELAND LIMITED
Oppositions
8
Patent
EP3083686
Grant Date
Mar 22, 2023
Title
Methods Of Treating Cancers Using Pd-1 Axis Binding Antagonists And Taxanes
Applicant
F.HOFFMANN-LA ROCHE AG
Oppositions
8
Patent
EP2683395
Grant Date
Aug 1, 2018
Title
Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders
Applicant
SORBONNE UNIVERSITÉ
Oppositions
8
Patent
EP3391890
Grant Date
Aug 25, 2021
Title
Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-Cyclodextrin
Applicant
MERCK SHARP & DOHME LLC
Oppositions
8
Patent
EP3015477
Grant Date
Aug 18, 2021
Title
High-Stability T-Cell Receptor And Preparation Method And Application Thereof
Applicant
LI, YI
Oppositions
8
Patent
EP4008357
Grant Date
Dec 28, 2022
Title
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant
GLAXOSMITHKLINE BIOLOGICALS S.A.
Oppositions
8

Need more information?

Feel free to send us a message here and we will get back to you